Inhibiting Stromal Class I HDACs Curbs Pancreatic Cancer Progression
Gaoyang Liang, Tae Gyu Oh, Nasun Hah…·Ronald M. Evans
This study shows that inhibiting stromal Class I HDACs reduces pancreatic cancer progression by targeting desmoplastic and pro-tumorigenic programs in cancer-associated fibroblasts.